Abstract
Iron deficiency (ID) is common amongst patients with heart failure (HF). The European Society of Cardiology (ESC) guidelines recommends intravenous (IV) Iron supplementation in symptomatic HF patients with reduced left ventricular ejection fraction (LVEF) and ID to alleviate HF symptoms and improve quality of life. The current study aims to assess adherence to the latest ESC guidelines in treatment of ID in HF patients admitted to non-cardiac (outlier) wards at St. George's University Hospital (SGH), London. The results were compared to standard practice at a dedicated heart failure unit (HFU) at SGH.
| Original language | English |
|---|---|
| DOIs | |
| Publication status | Published - 16 Nov 2024 |
| Event | American Heart Association Scientific Sessions 2024 - Chicago, U.S. Duration: 16 Nov 2024 → 17 Nov 2024 |
Conference
| Conference | American Heart Association Scientific Sessions 2024 |
|---|---|
| Period | 16/11/24 → 17/11/24 |
Bibliographical note
Note: An abstract of this poster was published in: Circulation (150), S1, 2024. ISSN: 0009-7322Organising Body: American Heart Association
Keywords
- Cardiovascular medicine